ARGX-119 (Congenital Myasthenic Syndromes)

Company: Argenx

Clinical trial(s): Phase 1b completed, Argenx have announced plans to advance the clinical development of this medicine.

Latest

MAM 2026 'Managing Our Mental Health' online session with Doon Jackson

Join us for the last of our 2026 MAM online sessions ‘Managing our Mental Health’ with Doon Jackson. We are so pleased to offer you the chance to meet Doon, a trained counsellor with 20+ years' experience working in the charity sector.
MAM Financial Wellbeing top tips

Our My Awareness Month (MAM) theme this year is ‘wellness’, and our Welfare Rights Team is offering a Zoom session on financial wellbeing. Join us for an interview with Charlie and Caroline, our Welfare Rights Advisers, about their top tips for financial wellbeing, and a chance to ask questions about all things welfare benefits and welfare rights.
July 2026 New Members Welcome and Introduction Zoom Session

If you are recently diagnosed and/or have just joined myaware because someone you know has been diagnosed, then come along to our ‘New Member Zoom Session’ where we will offer you practical and helpful support, and a chance to meet some of the team and others in similar situations.
Meg & Ethan raise money for Myaware

Ethan got diagnosed with Myasthenia Gravis at just 9 years old.